Ridgewood Investments’s Maravai LifeSciences MRVI Stock Holding History

Ridgewood Investments’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$2.41K	–	498
2025 Q2	$2.41K	Hold	1,000	–	–	﹤0.01%	653
2025 Q1	$2.21K	Hold	1,000	–	–	﹤0.01%	611
2024 Q4	$5.45K	Hold	1,000	–	–	﹤0.01%	574
2024 Q3	$8.31K	Hold	1,000	–	–	﹤0.01%	529
2024 Q2	$7.16K	Buy	+1,000	New	+$8.63K	﹤0.01%	548

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Ridgewood Investments's MRVI Position: Q3 2025 in Review

Ridgewood Investments sold out of Maravai LifeSciences (MRVI) in Q3 2025, closing a stake of 1,000 shares — an estimated $2.41K sold.

Ridgewood Investments first reported a position in MRVI in Q2 2024 and held it in 5 quarters. The position peaked at $8.31K in Q3 2024. 160 funds tracked by Wall St. Rank hold MRVI as of Q3 2025.

Ridgewood Investments reported no remaining Maravai LifeSciences position as of Q3 2025 after selling out during the quarter.
Ridgewood Investments sold 1,000 Maravai LifeSciences shares in Q3 2025, an estimated $2.41K.
Ridgewood Investments first reported a position in Maravai LifeSciences in Q2 2024 and held it in 5 quarters.
Ridgewood Investments's Maravai LifeSciences position peaked at $8.31K in Q3 2024.
160 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2025.

Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.